Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States

doi:10.1016/j.cgh.2017.11.045

. 2018 Aug;16(8):1356-1358.

doi: 10.1016/j.cgh.2017.11.045. Epub 2017 Dec 1.

Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States

George Cholankeril¹, Aijaz Ahmed²

Affiliations

¹ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.
² Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California. Electronic address: aijazahmed@stanford.edu.

PMID: 29199144
PMCID: PMC6467713
DOI: 10.1016/j.cgh.2017.11.045

Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States

George Cholankeril et al. Clin Gastroenterol Hepatol. 2018 Aug.

. 2018 Aug;16(8):1356-1358.

doi: 10.1016/j.cgh.2017.11.045. Epub 2017 Dec 1.

Authors

George Cholankeril¹, Aijaz Ahmed²

Affiliations

¹ Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.
² Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California. Electronic address: aijazahmed@stanford.edu.

PMID: 29199144
PMCID: PMC6467713
DOI: 10.1016/j.cgh.2017.11.045

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors disclose no conflicts.

Figures

**Figure 1.**
(A, B) Annual trends in the 3 leading indications for liver transplantation in the United States.

See this image and copyright information in PMC

Cited by

Trends in Hospitalizations and Liver Transplants Associated With Alcohol-Induced Liver Disease.
Sethi V, Bataller R, Liu H, Ruppert KM, Molinari M. Sethi V, et al. JAMA. 2024 Nov 14:e2421503. doi: 10.1001/jama.2024.21503. Online ahead of print. JAMA. 2024. PMID: 39541138
Therapeutic Potential of Lactiplantibacillus plantarum FB091 in Alleviating Alcohol-Induced Liver Disease through Gut-Liver Axis.
Lee SJ, Yang J, Keum GB, Kwak J, Doo H, Choi S, Park DG, Kim CH, Kim HB, Lee JH. Lee SJ, et al. J Microbiol Biotechnol. 2024 Oct 28;34(10):2100-2111. doi: 10.4014/jmb.2407.07051. Epub 2024 Aug 9. J Microbiol Biotechnol. 2024. PMID: 39300956 Free PMC article.
Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?
Hashem M, Medhat MA, Abdeltawab D, Makhlouf NA. Hashem M, et al. World J Transplant. 2024 Jun 18;14(2):90382. doi: 10.5500/wjt.v14.i2.90382. World J Transplant. 2024. PMID: 38947961 Free PMC article. Review.
A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Relapse.
Goswami A, Weinberg E, Coraluzzi L, Bittermann T, Nahas J, Addis S, Weinrieb R, Serper M. Goswami A, et al. Clin Transplant. 2024 Jul;38(7):e15381. doi: 10.1111/ctr.15381. Clin Transplant. 2024. PMID: 38940230
Multiomics Analysis of PCB126's Effect on a Mouse Chronic-Binge Alcohol Feeding Model.
Gripshover TC, Wahlang B, Head KZ, Luo J, Bolatimi OE, Smith ML, Rouchka EC, Chariker JH, Xu J, Cai L, Cummins TD, Merchant ML, Zheng H, Kong M, Cave MC. Gripshover TC, et al. Environ Health Perspect. 2024 Apr;132(4):47007. doi: 10.1289/EHP14132. Epub 2024 Apr 15. Environ Health Perspect. 2024. PMID: 38619879 Free PMC article.

See all "Cited by" articles

References

1. Cholankeril G, Li AA, March KL, et al. Improved outcomes in HCV patients following liver transplantation during the era of direct acting antiviral agents. Clin Gastroenterol Hepatol 2018; 16:452–453. - PubMed
1. Goldberg D, Ditah IC, Saeian K, et al. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation. Gastroenterology 2017;152:1090–1099. - PMC - PubMed
1. Flemming JA, Kim WR, Brosgart CL, et al. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology 2017;65:804–812. - PMC - PubMed
1. Barua S, Greenwald R, Grebely J, et al. Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Ann Intern Med 2015; 163:215–223. - PubMed
1. Grant BF, Chou SP, Saha TD, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001–2002 to 2012–2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry 2017; 74:911–923. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

T32 DK007056/DK/NIDDK NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Cholankeril G, Li AA, March KL, et al. Improved outcomes in HCV patients following liver transplantation during the era of direct acting antiviral agents. Clin Gastroenterol Hepatol 2018; 16:452–453. - PubMed

[2] Cholankeril G, Li AA, March KL, et al. Improved outcomes in HCV patients following liver transplantation during the era of direct acting antiviral agents. Clin Gastroenterol Hepatol 2018; 16:452–453. - PubMed

[3] Goldberg D, Ditah IC, Saeian K, et al. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation. Gastroenterology 2017;152:1090–1099. - PMC - PubMed

[4] Goldberg D, Ditah IC, Saeian K, et al. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation. Gastroenterology 2017;152:1090–1099. - PMC - PubMed

[5] Flemming JA, Kim WR, Brosgart CL, et al. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology 2017;65:804–812. - PMC - PubMed

[6] Flemming JA, Kim WR, Brosgart CL, et al. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology 2017;65:804–812. - PMC - PubMed

[7] Barua S, Greenwald R, Grebely J, et al. Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Ann Intern Med 2015; 163:215–223. - PubMed

[8] Barua S, Greenwald R, Grebely J, et al. Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Ann Intern Med 2015; 163:215–223. - PubMed

[9] Grant BF, Chou SP, Saha TD, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001–2002 to 2012–2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry 2017; 74:911–923. - PMC - PubMed

[10] Grant BF, Chou SP, Saha TD, et al. Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001–2002 to 2012–2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry 2017; 74:911–923. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States

Affiliations

Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical